Results 131 to 140 of about 45,441 (213)

Inhibition of NAMPT targets DNA damage response to sensitize alkylating chemotherapy in TP53 mutant mantle cell lymphoma. [PDF]

Blood Adv
Li N, Liu Y, Zhang L, Guo S, Wu Z, Xu Y, Yang M, Kong J, Che Y, Shao K, Yang H.   +10 more
europepmc   +1 more source

Inhibition of CDC20 suppresses the development and progression of mantle cell lymphoma through PI3K/AKT pathway. [PDF]

Ann Hematol
Chen Y, Yang P, Gao S, Liu S, Wang J, Zhang W, Jing H.   +6 more
europepmc   +1 more source

Thrombotic microangiopathy associated with mantle cell lymphoma: a case report. [PDF]

BMC Nephrol
Tonouchi Y, Hashimoto K, Iwabuchi R, Sakai H, Nimura T, Yamaka K, Nishikawa M, Yamaguchi A, Sonoda K, Kamijo Y.   +9 more
europepmc   +1 more source

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. [PDF]

Hemasphere
Jerkeman M, Aurer I, Campo E, Cheah CY, Clark J, Doorduijn J, Eyre TA, Fehr M, Giné E, Gomes da Silva M, Klener P, Ladetto M, Ribrag V, Shpilberg O, Walewski J, Dreyling M, EHA Guidelines Committee and the European MCL Network.   +16 more
europepmc   +1 more source

Mantle cell lymphoma presenting primarily as cutaneous lesions: A case report. [PDF]

World J Clin Cases
Zhou PY, Chen W, Wang L.
europepmc   +1 more source

The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma. [PDF]

Sci Rep
Fernández-Garnacho EM, Martínez-Muñoz C, Nadeu F, Clot G, Valero JG, Araujo-Ayala F, Martínez-Farran A, De Bolòs A, Colomer D, Mozas P, Rivero A, Giné E, López-Guillermo A, Salaverria I, López C, Beà S, Amador V, Demajo S, Jares P, Martín-Subero JI, Pérez-Galán P, Campo E, Hernández L.   +22 more
europepmc   +1 more source

B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma. [PDF]

Cell Commun Signal
Quaglia FM, Gambino S, Galasso M, Vegliante MC, Visco C, Scupoli MT.   +5 more
europepmc   +1 more source

Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Diagnostic and Therapeutic Challenge. [PDF]

EJHaem
Ye MT, Yang Y, You MJ.
europepmc   +1 more source

Real-world comparative effectiveness of Bruton tyrosine kinase inhibitors in relapsed/refractory mantle cell lymphoma. [PDF]

Blood Adv
Phillips T, Di M, Miller TA, Wang J, Pierre A, Maglinte GA, Seymour EK, Wang Y.   +7 more
europepmc   +1 more source

Identification and functional characterization of splicing factors implicated in mantle cell lymphoma aggressiveness. [PDF]

Sci Rep
Yosudjai J, Poohadsuan J, Samart P, Rodboon N, Issaragrisil S, Luanpitpong S.   +5 more
europepmc   +1 more source